Industry: Chemical & Material
Published Date: 2025-02-20
Pages: 138 Pages
Report ld: 4050117
Request Sample
Customized Report
The global market for Antiblocking Agents was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Anti-blocking agent is commonly used in the production and preparation of plastic film products, which can effectively improve the opening performance of the film. The earliest anti-blocking agent is inorganic talcum powder, diatomite, etc.
Asia-Pacific is expected to experience the highest growth in the market during the forecast period.
This report aims to provide a comprehensive presentation of the global market for Antiblocking Agents, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Antiblocking Agents by region & country, by Type, and by Application.
The Antiblocking Agents market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiblocking Agents.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Antiblocking Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Antiblocking Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Antiblocking Agents in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Antiblocking Agents Product Introduction
1.2 Global Antiblocking Agents Market Size Forecast
1.2.1 Global Antiblocking Agents Sales Value (2020-2031)
1.2.2 Global Antiblocking Agents Sales Volume (2020-2031)
1.2.3 Global Antiblocking Agents Sales Price (2020-2031)
1.3 Antiblocking Agents Market Trends & Drivers
1.3.1 Antiblocking Agents Industry Trends
1.3.2 Antiblocking Agents Market Drivers & Opportunity
1.3.3 Antiblocking Agents Market Challenges
1.3.4 Antiblocking Agents Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Antiblocking Agents Players Revenue Ranking (2024)
2.2 Global Antiblocking Agents Revenue by Company (2020-2025)
2.3 Global Antiblocking Agents Players Sales Volume Ranking (2024)
2.4 Global Antiblocking Agents Sales Volume by Company Players (2020-2025)
2.5 Global Antiblocking Agents Average Price by Company (2020-2025)
2.6 Key Manufacturers Antiblocking Agents Manufacturing Base and Headquarters
2.7 Key Manufacturers Antiblocking Agents Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Antiblocking Agents
2.9 Antiblocking Agents Market Competitive Analysis
2.9.1 Antiblocking Agents Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Antiblocking Agents Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiblocking Agents as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Organic
3.1.2 Inorganic
3.2 Global Antiblocking Agents Sales Value by Type
3.2.1 Global Antiblocking Agents Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Antiblocking Agents Sales Value, by Type (2020-2031)
3.2.3 Global Antiblocking Agents Sales Value, by Type (%) (2020-2031)
3.3 Global Antiblocking Agents Sales Volume by Type
3.3.1 Global Antiblocking Agents Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Antiblocking Agents Sales Volume, by Type (2020-2031)
3.3.3 Global Antiblocking Agents Sales Volume, by Type (%) (2020-2031)
3.4 Global Antiblocking Agents Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 PE Films
4.1.2 PP Films
4.1.3 Others
4.2 Global Antiblocking Agents Sales Value by Application
4.2.1 Global Antiblocking Agents Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Antiblocking Agents Sales Value, by Application (2020-2031)
4.2.3 Global Antiblocking Agents Sales Value, by Application (%) (2020-2031)
4.3 Global Antiblocking Agents Sales Volume by Application
4.3.1 Global Antiblocking Agents Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Antiblocking Agents Sales Volume, by Application (2020-2031)
4.3.3 Global Antiblocking Agents Sales Volume, by Application (%) (2020-2031)
4.4 Global Antiblocking Agents Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Antiblocking Agents Sales Value by Region
5.1.1 Global Antiblocking Agents Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Antiblocking Agents Sales Value by Region (2020-2025)
5.1.3 Global Antiblocking Agents Sales Value by Region (2026-2031)
5.1.4 Global Antiblocking Agents Sales Value by Region (%), (2020-2031)
5.2 Global Antiblocking Agents Sales Volume by Region
5.2.1 Global Antiblocking Agents Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Antiblocking Agents Sales Volume by Region (2020-2025)
5.2.3 Global Antiblocking Agents Sales Volume by Region (2026-2031)
5.2.4 Global Antiblocking Agents Sales Volume by Region (%), (2020-2031)
5.3 Global Antiblocking Agents Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Antiblocking Agents Sales Value, 2020-2031
5.4.2 North America Antiblocking Agents Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Antiblocking Agents Sales Value, 2020-2031
5.5.2 Europe Antiblocking Agents Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Antiblocking Agents Sales Value, 2020-2031
5.6.2 Asia Pacific Antiblocking Agents Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Antiblocking Agents Sales Value, 2020-2031
5.7.2 South America Antiblocking Agents Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Antiblocking Agents Sales Value, 2020-2031
5.8.2 Middle East & Africa Antiblocking Agents Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Antiblocking Agents Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Antiblocking Agents Sales Value
6.2.1 Key Countries/Regions Antiblocking Agents Sales Value, 2020-2031
6.2.2 Key Countries/Regions Antiblocking Agents Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Antiblocking Agents Sales Value, 2020-2031
6.3.2 United States Antiblocking Agents Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Antiblocking Agents Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Antiblocking Agents Sales Value, 2020-2031
6.4.2 Europe Antiblocking Agents Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Antiblocking Agents Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Antiblocking Agents Sales Value, 2020-2031
6.5.2 China Antiblocking Agents Sales Value by Type (%), 2024 VS 2031
6.5.3 China Antiblocking Agents Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Antiblocking Agents Sales Value, 2020-2031
6.6.2 Japan Antiblocking Agents Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Antiblocking Agents Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Antiblocking Agents Sales Value, 2020-2031
6.7.2 South Korea Antiblocking Agents Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Antiblocking Agents Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Antiblocking Agents Sales Value, 2020-2031
6.8.2 Southeast Asia Antiblocking Agents Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Antiblocking Agents Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Antiblocking Agents Sales Value, 2020-2031
6.9.2 India Antiblocking Agents Sales Value by Type (%), 2024 VS 2031
6.9.3 India Antiblocking Agents Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Evonik
7.1.1 Evonik Company Information
7.1.2 Evonik Introduction and Business Overview
7.1.3 Evonik Antiblocking Agents Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Evonik Antiblocking Agents Product Offerings
7.1.5 Evonik Recent Development
7.2 WR Grace
7.2.1 WR Grace Company Information
7.2.2 WR Grace Introduction and Business Overview
7.2.3 WR Grace Antiblocking Agents Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 WR Grace Antiblocking Agents Product Offerings
7.2.5 WR Grace Recent Development
7.3 Minerals Technologies
7.3.1 Minerals Technologies Company Information
7.3.2 Minerals Technologies Introduction and Business Overview
7.3.3 Minerals Technologies Antiblocking Agents Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Minerals Technologies Antiblocking Agents Product Offerings
7.3.5 Minerals Technologies Recent Development
7.4 Croda
7.4.1 Croda Company Information
7.4.2 Croda Introduction and Business Overview
7.4.3 Croda Antiblocking Agents Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Croda Antiblocking Agents Product Offerings
7.4.5 Croda Recent Development
7.5 PQ Corporation
7.5.1 PQ Corporation Company Information
7.5.2 PQ Corporation Introduction and Business Overview
7.5.3 PQ Corporation Antiblocking Agents Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 PQ Corporation Antiblocking Agents Product Offerings
7.5.5 PQ Corporation Recent Development
7.6 Madhu Silica
7.6.1 Madhu Silica Company Information
7.6.2 Madhu Silica Introduction and Business Overview
7.6.3 Madhu Silica Antiblocking Agents Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Madhu Silica Antiblocking Agents Product Offerings
7.6.5 Madhu Silica Recent Development
7.7 Solvay
7.7.1 Solvay Company Information
7.7.2 Solvay Introduction and Business Overview
7.7.3 Solvay Antiblocking Agents Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Solvay Antiblocking Agents Product Offerings
7.7.5 Solvay Recent Development
7.8 Fuji Silysia
7.8.1 Fuji Silysia Company Information
7.8.2 Fuji Silysia Introduction and Business Overview
7.8.3 Fuji Silysia Antiblocking Agents Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Fuji Silysia Antiblocking Agents Product Offerings
7.8.5 Fuji Silysia Recent Development
7.9 IQE Group
7.9.1 IQE Group Company Information
7.9.2 IQE Group Introduction and Business Overview
7.9.3 IQE Group Antiblocking Agents Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 IQE Group Antiblocking Agents Product Offerings
7.9.5 IQE Group Recent Development
7.10 Tosoh Silica
7.10.1 Tosoh Silica Company Information
7.10.2 Tosoh Silica Introduction and Business Overview
7.10.3 Tosoh Silica Antiblocking Agents Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Tosoh Silica Antiblocking Agents Product Offerings
7.10.5 Tosoh Silica Recent Development
7.11 NYACOL Nano Technologies
7.11.1 NYACOL Nano Technologies Company Information
7.11.2 NYACOL Nano Technologies Introduction and Business Overview
7.11.3 NYACOL Nano Technologies Antiblocking Agents Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 NYACOL Nano Technologies Antiblocking Agents Product Offerings
7.11.5 NYACOL Nano Technologies Recent Development
7.12 S-Chemtech
7.12.1 S-Chemtech Company Information
7.12.2 S-Chemtech Introduction and Business Overview
7.12.3 S-Chemtech Antiblocking Agents Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 S-Chemtech Antiblocking Agents Product Offerings
7.12.5 S-Chemtech Recent Development
7.13 Baerlocher
7.13.1 Baerlocher Company Information
7.13.2 Baerlocher Introduction and Business Overview
7.13.3 Baerlocher Antiblocking Agents Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Baerlocher Antiblocking Agents Product Offerings
7.13.5 Baerlocher Recent Development
7.14 Imerys
7.14.1 Imerys Company Information
7.14.2 Imerys Introduction and Business Overview
7.14.3 Imerys Antiblocking Agents Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Imerys Antiblocking Agents Product Offerings
7.14.5 Imerys Recent Development
7.15 Hoffmann Mineral
7.15.1 Hoffmann Mineral Company Information
7.15.2 Hoffmann Mineral Introduction and Business Overview
7.15.3 Hoffmann Mineral Antiblocking Agents Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Hoffmann Mineral Antiblocking Agents Product Offerings
7.15.5 Hoffmann Mineral Recent Development
7.16 EP Mineral
7.16.1 EP Mineral Company Information
7.16.2 EP Mineral Introduction and Business Overview
7.16.3 EP Mineral Antiblocking Agents Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 EP Mineral Antiblocking Agents Product Offerings
7.16.5 EP Mineral Recent Development
8 Industry Chain Analysis
8.1 Antiblocking Agents Industrial Chain
8.2 Antiblocking Agents Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Antiblocking Agents Sales Model
8.5.2 Sales Channel
8.5.3 Antiblocking Agents Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Antiblocking Agents was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-09
Pages: 149
USD 3950.00
(Single User License)
The global Antiblocking Agents market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 148
USD 2900.00
(Single User License)
The global Antiblocking Agents market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-24
Pages: 179
USD 4900.00
(Single User License)
The global Antiblocking Agents market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 101
USD 4250.00
(Single User License)
The global market for Antiblocking Agents was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 115
USD 2900.00
(Single User License)
Anti-blocking agent is commonly used in the production and preparation of plastic film products, which can effectively improve the opening performance of the film. The earliest anti-blocking agent is inorganic talcum powder, diatomite, etc.
Published Date: 2024-04-08
Pages: 115
USD 4900.00
(Single User License)
Anti-blocking agent is commonly used in the production and preparation of plastic film products, which can effectively improve the opening performance of the film. The earliest anti-blocking agent is inorganic talcum powder, diatomite, etc.
Published Date: 2024-02-22
Pages: 142
USD 3950.00
(Single User License)
Anti-blocking agent is commonly used in the production and preparation of plastic film products, which can effectively improve the opening performance of the film. The earliest anti-blocking agent is inorganic talcum powder, diatomite, etc.
Published Date: 2024-01-16
Pages: 114
USD 2900.00
(Single User License)
The global market for Antiblocking Agents was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-09
Pages: 149
The global Antiblocking Agents market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 148
The global Antiblocking Agents market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-24
Pages: 179
The global Antiblocking Agents market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 101
The global market for Antiblocking Agents was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 115
Anti-blocking agent is commonly used in the production and preparation of plastic film products, which can effectively improve the opening performance of the film. The earliest anti-blocking agent is inorganic talcum powder, diatomite, etc.
Published: 2024-04-08
Pages: 115
Anti-blocking agent is commonly used in the production and preparation of plastic film products, which can effectively improve the opening performance of the film. The earliest anti-blocking agent is inorganic talcum powder, diatomite, etc.
Published: 2024-02-22
Pages: 142
Anti-blocking agent is commonly used in the production and preparation of plastic film products, which can effectively improve the opening performance of the film. The earliest anti-blocking agent is inorganic talcum powder, diatomite, etc.
Published: 2024-01-16
Pages: 114
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now